Evidence map›Paper›PMID 38647045›Full record

ArticleNucleic acids research2024

Live-cell imaging reveals the trade-off between target search flexibility and efficiency for Cas9 and Cas12a.

Lorenzo Olivi, Cleo Bagchus, Victor Pool, Ezra Bekkering, Konstantin Speckner, Hidde Offerhaus, Wen Y Wu, Martin Depken, Koen J A Martens, Raymond H J Staals and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Lorenzo OliviLaboratory of Microbiology, Wageningen University & Research, Wageningen, The Netherlands.
Cleo BagchusLaboratory of Microbiology, Wageningen University & Research, Wageningen, The Netherlands.
Victor PoolLaboratory of Microbiology, Wageningen University & Research, Wageningen, The Netherlands.
Ezra BekkeringLaboratory of Biophysics, Wageningen University & Research, Wageningen, The Netherlands.
Konstantin SpecknerLaboratory of Biophysics, Wageningen University & Research, Wageningen, The Netherlands.
Hidde OfferhausDepartment of Bionanoscience, Kavli Institute of Nanoscience, Delft University of Technology, Delft, The Netherlands.
Wen Y WuLaboratory of Microbiology, Wageningen University & Research, Wageningen, The Netherlands.
Martin DepkenDepartment of Bionanoscience, Kavli Institute of Nanoscience, Delft University of Technology, Delft, The Netherlands.
Koen J A MartensLaboratory of Biophysics, Wageningen University & Research, Wageningen, The Netherlands.
Raymond H J StaalsLaboratory of Microbiology, Wageningen University & Research, Wageningen, The Netherlands.ORCID 0000-0002-5741-9457
Johannes HohlbeinLaboratory of Biophysics, Wageningen University & Research, Wageningen, The Netherlands.ORCID 0000-0001-7436-2221
Wageningen University & Research · NLDelft University of Technology · NL

Funding

NWOThe Netherlands Organization of Scientific Research 024.003.019VIDI VI.Vidi.203.074
6 · The paper itself

Abstract

CRISPR-Cas systems have widely been adopted as genome editing tools, with two frequently employed Cas nucleases being SpyCas9 and LbCas12a. Although both nucleases use RNA guides to find and cleave target DNA sites, the two enzymes differ in terms of protospacer-adjacent motif (PAM) requirements, guide architecture and cleavage mechanism. In the last years, rational engineering led to the creation of PAM-relaxed variants SpRYCas9 and impLbCas12a to broaden the targetable DNA space. By employing their catalytically inactive variants (dCas9/dCas12a), we quantified how the protein-specific characteristics impact the target search process. To allow quantification, we fused these nucleases to the photoactivatable fluorescent protein PAmCherry2.1 and performed single-particle tracking in cells of Escherichia coli. From our tracking analysis, we derived kinetic parameters for each nuclease with a non-targeting RNA guide, strongly suggesting that interrogation of DNA by LbdCas12a variants proceeds faster than that of SpydCas9. In the presence of a targeting RNA guide, both simulations and imaging of cells confirmed that LbdCas12a variants are faster and more efficient in finding a specific target site. Our work demonstrates the trade-off of relaxing PAM requirements in SpydCas9 and LbdCas12a using a powerful framework, which can be applied to other nucleases to quantify their DNA target search.

Indexed as

CRISPR-Associated Protein 9CRISPR-Associated ProteinsCRISPR-Cas SystemsGene EditingBacterial ProteinsDNAEndodeoxyribonucleasesEscherichia coliKineticsRNA, Guide, CRISPR-Cas SystemsBacterial ProteinsCas12a proteinCRISPR-Associated Protein 9CRISPR-Associated ProteinsDNAEndodeoxyribonucleasesRNA, Guide, CRISPR-Cas Systems

Identifiers

PMID38647045
PMCPMC11109954
OpenAlexW4395010519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.